Estrogen Receptor Negative Breast Cancer (1)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast (1)

Recurrent Breast Cancer (1)

Stage IV Breast Cancer (1)

Triple Negative Breast Cancer (1)

Triple-negative Breast Cancer (1)

Terminated (1)

phase 1/phase 2 (1)

Vanderbilt-Ingram Cancer Center (1)

Genentech, Inc. (1)

National Cancer Institute (NCI) (1)

cisplatin (1)

dynamic contrast-enhanced mri, diffusion-weighted mri & chemical exchange saturation transfer mri (1)

gdc -0941 (1)

laboratory biomarker analysis (1)

pharmacological study (1)

drug (1)

other (1)

procedure (1)

Other (1)

Interventional (1)

estrogen receptor negative breast cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

May 22, 2017